These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20222917)

  • 1. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs).
    Valkhoff VE; van Soest EM; Sturkenboom MC; Kuipers EJ
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1218-28. PubMed ID: 20222917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA; Derry S; Phillips CJ; McQuay HJ
    BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals.
    Fosbøl EL; Køber L; Torp-Pedersen C; Gislason GH
    Expert Opin Drug Saf; 2010 Nov; 9(6):893-903. PubMed ID: 20569079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
    Vakil N
    Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
    Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
    Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs.
    Castellsague J; Holick CN; Hoffman CC; Gimeno V; Stang MR; Perez-Gutthann S
    Pharmacotherapy; 2009 Dec; 29(12):1397-407. PubMed ID: 19947799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
    Rostom A; Moayyedi P; Hunt R;
    Aliment Pharmacol Ther; 2009 Mar; 29(5):481-96. PubMed ID: 19053986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
    Lazzaroni M; Battocchia A; Bianchi Porro G
    Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs.
    Chiba T; Sato K; Kudara N; Shinozaki H; Ikeda K; Sato K; Endo M; Orii S; Suzuki K
    Inflammopharmacology; 2008 Feb; 16(1):16-20. PubMed ID: 18256801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
    Etminan M; Lévesque L; Fitzgerald JM; Brophy JM
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1188-92. PubMed ID: 19298582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
    Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT
    Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.
    Sostres C; Gargallo CJ; Arroyo MT; Lanas A
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):121-32. PubMed ID: 20227026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin.
    Cheetham TC; Levy G; Niu F; Bixler F
    Ann Pharmacother; 2009 Nov; 43(11):1765-73. PubMed ID: 19809010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
    Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
    Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications.
    Lanas A; Sopeña F
    Gastroenterol Clin North Am; 2009 Jun; 38(2):333-52. PubMed ID: 19446262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study].
    Lanas A; Muñoz M; Caballero Correa M; Martínez Jiménez P;
    Gastroenterol Hepatol; 2010 Feb; 33(2):80-91. PubMed ID: 19931944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonvariceal upper gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drugs in Metropolitan Lima].
    Salvatierra Laytén G; de la Cruz Romero L; Paulino Merino M; Vidal Vidal V; Rivera Dávila C; Cano Chuquilin A; Frisancho Velarde O
    Rev Gastroenterol Peru; 2006; 26(1):13-20. PubMed ID: 16622483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.